<SEC-DOCUMENT>0000928464-20-000069.txt : 20201105
<SEC-HEADER>0000928464-20-000069.hdr.sgml : 20201105
<ACCEPTANCE-DATETIME>20201105164157
ACCESSION NUMBER:		0000928464-20-000069
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20201105
DATE AS OF CHANGE:		20201105

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HERBALIFE NUTRITION LTD.
		CENTRAL INDEX KEY:			0001180262
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-80216
		FILM NUMBER:		201291172

	BUSINESS ADDRESS:	
		STREET 1:		P.O. BOX 309GT
		STREET 2:		UGLAND HOUSE, SOUTH CHURCH STREET
		CITY:			GEORGE TOWN
		STATE:			E9
		ZIP:			00000
		BUSINESS PHONE:		310 410 9600

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 309GT
		STREET 2:		UGLAND HOUSE, SOUTH CHURCH STREET
		CITY:			GEORGE TOWN
		STATE:			E9
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HERBALIFE LTD.
		DATE OF NAME CHANGE:	20041214

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WH HOLDINGS CAYMAN ISLANDS LTD
		DATE OF NAME CHANGE:	20020814

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICAHN CARL C
		CENTRAL INDEX KEY:			0000921669
		STANDARD INDUSTRIAL CLASSIFICATION:	UNKNOWN SIC - 0000 [0000]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		C/O ICAHN ENTERPRISES L.P.
		STREET 2:		16690 COLLINS AVE., PH-1
		CITY:			SUNNY ISLES BEACH
		STATE:			FL
		ZIP:			33160
		BUSINESS PHONE:		305-422-4145

	MAIL ADDRESS:	
		STREET 1:		C/O ICAHN ENTERPRISES L.P.
		STREET 2:		16690 COLLINS AVE., PH-1
		CITY:			SUNNY ISLES BEACH
		STATE:			FL
		ZIP:			33160

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICAHN CARL C ET AL
		DATE OF NAME CHANGE:	19950612
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>hlfsch13da11052020.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Icahn
         Document created using EDGARfilings PROfile 7.0.1.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center;">SCHEDULE 13D</div>
    <div><br>
    </div>
    <div style="text-align: center;">Under the Securities Exchange Act of 1934</div>
    <div style="text-align: center;">(Amendment No. 21)*</div>
    <div><br>
    </div>
    <div style="text-align: center;">Herbalife Nutrition Ltd.</div>
    <div style="text-align: center;">(Name of Issuer)</div>
    <div><br>
    </div>
    <div style="text-align: center;">Common Shares, par value $0.0005 per share</div>
    <div style="text-align: center;">(Title of Class of Securities)</div>
    <div><br>
    </div>
    <div style="text-align: center;">G4412G101</div>
    <div style="text-align: center;">(CUSIP Number)</div>
    <div><br>
    </div>
    <div style="text-align: center;">Andrew Langham, Esq.</div>
    <div style="text-align: center;">Icahn Capital LP</div>
    <div style="text-align: center;">16690 Collins Avenue, Suite PH-1</div>
    <div style="text-align: center;">Sunny Isles Beach, FL 33160</div>
    <div style="text-align: center;">(305) 422-4100</div>
    <div><br>
    </div>
    <div style="text-align: center;">(Name, Address and Telephone Number of Person Authorized to</div>
    <div style="text-align: center;">Receive Notices and Communications)</div>
    <div><br>
    </div>
    <div style="text-align: center;">November 4, 2020</div>
    <div style="text-align: center;">(Date of Event which Requires Filing of this Statement)</div>
    <div><br>
    </div>
    <div style="text-align: justify;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing
      this schedule because of Section 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box / /.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d&#8209;7 for other
      parties to whom copies are to be sent.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities,
      and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act
      of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;">SCHEDULE 13D</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">This statement constitutes Amendment No. 21 to the Schedule 13D relating to the Common Shares, par value $0.001 per share (the
      &#8220;Shares&#8221;), issued by Herbalife Nutrition Ltd. (the &#8220;Issuer&#8221;), and hereby amends the Schedule 13D filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 14, 2013 (as previously amended, the &#8220;Schedule 13D&#8221;), to furnish the additional
      information set forth herein. All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="background-color: #FFFFFF;">
      <div style="text-align: justify;">Item 4. Purpose of Transaction</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Item 4 of the Schedule 13D is hereby amended by the addition of the following:</div>
      <div><br>
      </div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div style="text-align: justify; text-indent: 36pt;">On November 4, 2020, in connection with the Issuer&#8217;s announcement of a distribution of warrants pro rata to all of its shareholders, the Reporting Persons and the Issuer entered into an agreement (the &#8220;Letter
          Agreement&#8221;) with respect to the Second Amended and Restated Support Agreement dated July 15, 2016, between the Reporting Persons and the Issuer. A copy of the
          Letter Agreement is filed herewith as Exhibit 1 and incorporated herein by reference.</div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify;">Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">Item 6 of the Schedule 13D is hereby amended by the addition of the following:</div>
      <div><br>
      </div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div style="text-align: justify; text-indent: 36pt;">The disclosure set forth above in Item 4 is incorporated herein by reference.</div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify;">Item 7. Material to be Filed as Exhibits</div>
      <div><br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z4314ed93d570452780f15c584207d802" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; align: right;">
            <div>1.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: justify;">Letter Agreement dated November 4, 2020, between the Reporting Persons and the Issuer (incorporated by reference to Exhibit 10.1 to the Form 8-K
              filed by the Issuer with the Securities and Exchange Commission on November 5, 2020).</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;">SIGNATURE</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;">After reasonable inquiry and to the best of each of the undersigned knowledge and belief, each of the undersigned certifies that the
      information set forth in this statement is true, complete and correct.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Dated: November 5, 2020</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify;">ICAHN PARTNERS LP</div>
    <div style="text-align: justify;">ICAHN PARTNERS MASTER FUND LP</div>
    <div style="text-align: justify;">ICAHN ONSHORE LP</div>
    <div style="text-align: justify;">ICAHN OFFSHORE LP</div>
    <div style="text-align: justify;">ICAHN CAPITAL LP</div>
    <div style="text-align: justify;">IPH GP LLC</div>
    <div><br>
    </div>
    <div style="text-align: justify;">By:<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><u>/s/ Irene March</u></div>
    <div style="text-align: justify; text-indent: 36pt;">Name: Irene March</div>
    <div style="text-align: justify; text-indent: 36pt;">Title: Executive Vice President</div>
    <div><br>
    </div>
    <div style="text-align: justify;">BECKTON CORP.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">By:<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><u>/s/ Irene March</u></div>
    <div style="text-align: justify; text-indent: 36pt;">Name: Irene March</div>
    <div style="text-align: justify; text-indent: 36pt;">Title: Executive Vice President</div>
    <div><br>
    </div>
    <div style="text-align: justify;">ICAHN ENTERPRISES HOLDINGS L.P.</div>
    <div style="text-align: justify; text-indent: 36pt;">By: Icahn Enterprises G.P. Inc., its general partner</div>
    <div style="text-align: justify;">ICAHN ENTERPRISES G.P. INC.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">By:<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font><u>/s/ SungHwan Cho</u></div>
    <div style="text-align: justify; text-indent: 36pt;">Name: SungHwan Cho</div>
    <div style="text-align: justify; text-indent: 36pt;">Title: Chief Financial Officer</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify;"><u>/s/ Carl C. Icahn</u><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 108pt">&#160;</font></div>
    <div style="text-align: justify;">CARL C. ICAHN</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;">[Signature Page of Schedule 13D, Amendment No. 21 &#8211; Herbalife Ltd.]</div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
